Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.
The existence of an endogenous cannabinoid system was demonstrated conclusively with the discovery of endogenous brain constituents capable of activating the cannabinoid receptors functionally. These compounds are synthesized by neuronal cells and inactivated through re-uptake and enzymatic hydrolysis by both neurons and astrocytes. In analogy with the endorphins they can be referred to as endocannabinoids. Apart from the identification of their metabolic pathways, research carried out in the past six years has focused on the possible cellular and molecular targets for the actions of endocannabinoids. These studies have confirmed a similarity between the endocannabinoids and the psychoactive substance in marijuana, delta9(-)-tetrahydrocannabinol, and have suggested a role for endocannabinoids in the modulation of neurotransmitter action and release.
Di Marzo
V
V
Istituto per la Chimica di Molecole di Interesse Biologico, CNR, Napoli, Italy.
Melck
D
D
Bisogno
T
T
De Petrocellis
L
L
D000818:Animals; D001253:Astrocytes / Q000378:metabolism; D001921:Brain / Q000378:metabolism; D063385:Cannabinoid Receptor Modulators; D002186:Cannabinoids / Q000032:analysis* / Q000378:metabolism; D063388:Endocannabinoids; D006801:Humans; D008024:Ligands; D009474:Neurons / Q000378:metabolism; D018377:Neurotransmitter Agents / Q000378:metabolism* / Q000502:physiology; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug / Q000737:chemistry / Q000302:isolation & purification / Q000378:metabolism*; D013569:Synapses / Q000378:metabolism
D063385:Cannabinoid Receptor Modulators; D002186:Cannabinoids; D063388:Endocannabinoids; D008024:Ligands; D018377:Neurotransmitter Agents; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug